St. Jude research linked mesenchymal to adrenergic cell change mechanism in MYCN-linked neuroblastoma to high MYCN levels, driven by KDM4 induction (IMAGE)
Caption
Corresponding author Jun Yang, MD, PhD, (left) and co-first authors Jie Fang, PhD, (center) and Shivendra Singh, PhD (right), identified a window of opportunity to treat high-risk MYCN-amplified neuroblastoma.
Credit
Courtesy of St. Jude Children's Research Hospital
Usage Restrictions
none
License
Original content